Journal ArticleOPEN ACCESS

Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancer

Cochrane Database of Systematic Reviews (2015) 2015(12)
DOI: 10.1002/14651858.CD012007
1Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the effectiveness and safety of weekly paclitaxel with that of three-weekly paclitaxel, in combination with carboplatin, as first-line chemotherapy treatment for ovarian cancer.

Cite

CITATION STYLE

APA

Syn, N. L. X., Goh, R. M., Goh, B. C., Soon, Y. Y., & Tan, D. S. P. (2015). Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with ovarian cancer. Cochrane Database of Systematic Reviews, 2015(12). https://doi.org/10.1002/14651858.CD012007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free